How big is Applied DNA Sciences, Inc.?

As of Jun 18, Applied DNA Sciences, Inc. has a market capitalization of 2.45 million and reported net sales of 3.79 million with a net loss of 7.47 million over the latest four quarters. The company's balance sheet shows shareholder's funds of 9.14 million and total assets of 12.79 million as of Sep 24.

As of Jun 18, Applied DNA Sciences, Inc. has a market capitalization of 2.45 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the company reported net sales of 3.79 million for the latest four quarters. During the same period, the net profit was recorded at -7.47 million, indicating a loss.<BR><BR>As of Sep 24, the company's balance sheet shows shareholder's funds amounting to 9.14 million and total assets of 12.79 million.

What does Applied DNA Sciences, Inc. do?

Applied DNA Sciences, Inc. develops security solutions for the Pharmaceuticals & Biotechnology industry and has a market cap of $2.45 million. As of March 2025, it reported net sales of $1 million and a net loss of $3 million.

Overview: <BR>Applied DNA Sciences, Inc. is engaged in creating security solutions addressing the challenges of modern commerce within the Pharmaceuticals & Biotechnology industry, classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Net Sales: 1 Million (Quarterly Results - Mar 2025) <BR>Net Profit: -3 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 2.45 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.61 <BR>Return on Equity: -122.44% <BR>Price to Book: 0.23<BR><BR>Contact Details: <BR>Address: 50 Health Sciences Dr, STONY BROOK NY: 11790-3349 <BR>Tel: 1 631 2408800 <BR>Fax: 1 631 2408900 <BR>Website: http://www.adnas.com/

Who are in the management team of Applied DNA Sciences, Inc.?

As of March 2022, the management team of Applied DNA Sciences, Inc. includes Dr. James Hayward as Chairman, President, and CEO, with Directors Mr. Robert Catell and Ms. Elizabeth Ferguson, and Independent Directors Mr. Scott Anchin, Mr. John Bitzer, and Mr. Joseph Ceccoli.

As of March 2022, the management team of Applied DNA Sciences, Inc. includes Dr. James Hayward, who serves as the Chairman of the Board, President, and Chief Executive Officer. Additionally, the Board of Directors features Mr. Robert Catell and Ms. Elizabeth Ferguson as Directors, along with Mr. Scott Anchin, Mr. John Bitzer, and Mr. Joseph Ceccoli, who are all Independent Directors.

Should I buy, sell or hold Applied DNA Sciences, Inc.?

Is Applied DNA Sciences, Inc. technically bullish or bearish?

As of August 19, 2025, Applied DNA Sciences, Inc. is in a bearish trend with weak strength indicators, underperforming the S&P 500 significantly with a year-to-date return of -98.12%.

As of 19 August 2025, the technical trend for Applied DNA Sciences, Inc. has changed from mildly bearish to bearish. The current stance is bearish with weak strength indicated by the daily moving averages and monthly Bollinger Bands, both signaling bearish conditions. The MACD shows mildly bullish signals on the weekly and monthly time frames, but this is contradicted by the monthly RSI, which is bearish. Additionally, the Dow Theory indicates a bearish trend on the monthly scale. <BR><BR>In terms of performance, the stock has significantly underperformed compared to the S&P 500, with a year-to-date return of -98.12% versus the S&P 500's 12.22%, highlighting a stark divergence in performance.